Acquisition Of Anagrelide 0.5 Mg Capsules, Apalutamide 60 Mg Tablet, Golimumab 50 Mg/0.5 Ml Sol Inj Pen 0.5 Ml Sc, Guselkumab 100 Mg/1 Ml Sol Inj Pen 1 Ml Sc, Antilymphocyte Immunoglobulin (Rabbit) 25 M.

  Address - Portugal

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 99428330

  Document Type - Tender Notices

Description - Description: Anagrelide 0.5 mg caps, Apalutamide 60 mg comp, Golimumab 50 mg/0.5 ml sol inj pen 0.5 ml SC, Guselkumab 100 mg/1 ml sol inj pen 1 ml SC, Antilymphocyte immunoglobulin (rabbit) 25 mAcquisition of Anagrelide 0.5 mg caps, Apalutamide 60 mg comp, Golimumab 50 mg/0.5 ml sol inj pen 0.5 ml SC, Guselkumab 100 mg/1 ml sol inj pen 1 ml SC, Antilymphocyte immunoglobulin (rabbit) 25 mg/5 ml powder conc sol inj fr IV, Mycophenolate mofetil 1000 mg/5 ml powder susp oral fr 175 ml, Ofatumumab 20 mg/0.4 ml sol inj pen 0.4 ml SC, Sunitinib 12.5 mg capsules and Tacrolimus 0.5 mg LP capsuleslocal title:: Aquisição de Anagrelida 0.5 mg cáps, Apalutamida 60 mg comp, Golimumab 50 mg/0.5 ml sol i

Mt Ref Id - 99428330

Deadline - Nov 30, -0001